Screener
The Beauty Health Company SKIN Debt Issuance Proceeds
Debt Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by The Beauty Health Company in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromConvertibleDebt.
The source filing: The Beauty Health Company’s 10-K, filed March 12, 2026.
- Filed
- Mar 12, 2026, 5:24 PM EDT
- Fiscal year
- FY2025
- Accession
- 0001628280-26-017376
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 |
|---|---|---|---|
| Net cash used for investing activities | (5,163) | (6,794) | (31,507) |
| Cash flows from financing activities: | |||
| Repurchase of 2026 Notes in connection with exchange | (392,583) | — | — |
| Issuance of 2028 Notes in connection with exchange, net | 237,601 | — | — |
| Repurchase of 2026 Notes | (18,372) | (156,082) | — |
| Payment of tax withholdings on vested stock awards | (1,572) | (1,957) | (3,234) |
| Repurchase of common stock | — | — | (30,155) |
| Payment of accelerated share repurchases | — | — | (2,240) |
Item 8. Financial Statements and Supplementary Data.
FAQ
- What is The Beauty Health Company's debt issuance proceeds?
- The Beauty Health Company (SKIN) reported debt issuance proceeds of $59.4M in Q4 2025.
- What is the long-term trend for The Beauty Health Company's debt issuance proceeds?
- Over 2 years (2021 to 2025), The Beauty Health Company's debt issuance proceeds has grown at a -43.7% compound annual growth rate (CAGR), from $750M to $237.6M.
- What does debt issuance proceeds mean?
- Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.
Ask your AI about The Beauty Health Company's debt issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude